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Abstract
Background: Autism Spectrum Conditions (ASCs) are characterized by a high degree of clinical
heterogeneity, but the extent to which this variation represents a severity gradient versus discrete
phenotypes is unclear. This issue has complicated genetic studies seeking to investigate the genetic basis
of the high hereditability observed clinically in those with an ASC. The aim of this study was to examine
the possible clustering of symptoms associated with ASCs to determine whether the observed distribution
of symptom type and severity supported either a severity or a symptom subgroup model to account for
the phenotypic variation observed within the ASCs.
Methods: We investigated the responses of a group of adults with higher functioning ASCs on the fifty
clinical features examined in the Autism Spectrum Quotient, a screening questionnaire used in the
diagnosis of higher functioning ASCs. In contrast to previous studies we have used this instrument with no
a priori assumptions about any underlying factor structure of constituent items. The responses obtained
were analyzed using complete linkage hierarchical cluster analysis. For the members of each cluster
identified the mean score on each Autism Spectrum Quotient question was calculated.
Results: Autism Spectrum Quotient responses from a total of 333 individuals between the ages of 16.6
and 78.0 years were entered into the hierarchical cluster analysis. The four cluster solution was the one
that generated the largest number of clusters that did not also include very small cluster sizes, defined as
a membership comprising 10 individuals or fewer. Examination of these clusters demonstrated that they
varied in total Autism Spectrum Quotient but that the profiles across the symptoms comprising the
Autism Spectrum Quotient did not differ independently of this severity factor.
Conclusion: These results are consistent with a unitary spectrum model, suggesting that the clinical
heterogeneity observed in those with an autistic spectrum condition at the higher-IQ end of the spectrum
is associated with a gradient in the overall severity of the ASC rather than with the presence of different
specific symptom profiles in different individuals. The implications of this for genetic research are
considered.
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Autism and the related disorders Asperger Syndrome (AS)
and Pervasive Developmental Disorder Not Otherwise
Specified (PDDNOS) are characterised by qualitative
impairments of social interaction and communication,
and restricted and repetitive patterns of behaviour of early
childhood onset. They are now widely accepted as form-
ing a spectrum of disorders, the so-called autism spectrum
of conditions (ASCs), with the term 'spectrum' indicating
the variation in the clinical phenotype observed [1]. Twin
and family studies have demonstrated the etiological role
of a number of genes [2-4], and linkage and association
studies have begun to converge on regions of susceptibil-
ity and possible candidate genes respectively (reviewed in
[5])
Unfortunately, however, the genetic research has been
plagued with a failure to replicate findings, and with
regions of linkage seemingly occurring on the majority of
chromosomes. Recent research has taken two different
approaches to address this. First, pooling data to increase
sample sizes, such as with the Autism Genetic Resource
Exchange [6] database, and secondly, examining sub-
groups within the autism spectrum, such as language
delayed groups, those exhibiting repetitive patterns of
behaviour and those meeting the more specific criteria for
AS.
This latter approach is predicated on a model in which the
spectrum is not a unitary concept, but, instead, consists of
subgroups with unique but overlapping genetic influences
[7,8]. At its most basic level this model argues that differ-
ent sets of genes are responsible for the social, communi-
cation and behavioural impairments respectively. In
support of this, the twin study of Ronald et al. 2006 [8]
identified low phenotypic correlations between the three
subscales of social interaction, communication and
restricted/repetitive patterns of behaviour. There is also
some genetic evidence to support this model. Shao [9],
demonstrated improved linkage signals on chromosome
15q for a 'restricted and repetitive' behavioural subgroup,
consistent with genes contributing differentially to these
phenotypic characteristics. Although the genetic studies of
Bradford et al. [10] and Buxbaum et al. [11] appear to also
support this model, by considering language delay these
studies have simply stratified their samples according to a
general cognitive characteristic.
In contrast, however, other researchers have argued for a
severity gradient [12,13], with presentation being modi-
fied according to the severity of autism symptoms. How-
ever, even if a severity gradient is the correct model it is
still unclear whether this represents variation in severity of
the core phenotype per se, or is a reflection of another fac-
tor, such as the impact of cognitive function on the expres-
sion of the phenotype.
There are a number of considerations that might explain
the discrepancies between studies. An important consider-
ation is the design of the studies. For example, Spiker's
and Silverman's examined clustering according to the
Autism Diagnostic Interview (ADI-R), whilst Constan-
tino's [13] examined clustering on the Social Reciprocity
Scale (SRS) and Ronald's [8] examined multivariate
model fitting according to Childhood Asperger Syndrome
Test (CAST). Clearly all questionnaires differ, as some are
designed as screening instruments whilst others are aimed
at diagnosis, some are concerned with higher functioning
individuals whilst others are interested in a wider range of
disability and some are self-report whilst others are
informant-based. Other differences between studies
included whether multiplex families or singletons were
investigated, the sample sizes and the cognitive range of
subjects included. All of these factors may have influenced
the results.
In this current study, adult singletons with higher func-
tioning ASCs are examined for their clustering on the fifty
clinical features examined in the Autism Spectrum Quo-
tient [14], a screening questionnaire used in the diagnosis
of higher functioning ASCs. In contrast to previous studies
we have used the AQ and have made no a priori assump-
tions about the underlying factor structure of this ques-
tionnaire and the clinical features it identifies. Our aim
was to examine the possible clustering of responses within
our study population and to determine whether the data
obtained supported either a severity or a subgroup model
to account for the phenotypic variation observed within
the ASCs. Previous studies have sampled children with
ASCs, but this is the first to examine an adult sample in
this way. There is evidence that for a significant minority
the ASC symptoms improve with age [15], suggesting that
there may be different subgroups within this population,
and raising the possibility that a different pattern of clus-
tering will be observed among the adult ASC population.
In addition, by including only those with higher function-
ing ASCs the effects of cognitive impairment per se on clus-
tering are relatively reduced.
Methods
The individuals comprising the study population were
drawn from across the UK and had either been referred to
a specialist diagnostic clinic (CLASS, or Cambridge
Lifespan Asperger Syndrome Service) for clarification of a
possible diagnosis of Asperger's syndrome or high func-
tioning autism or had contacted the University of Cam-
bridge Autism Research Centre (ARC) volunteer database.
All participating individuals were aged at least 16 years
and met diagnostic criteria for an ASC according to DSM-Page 2 of 6
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ARC volunteer database and 175 from the diagnostic
clinic (CLASS), making a total of 388.
The characteristics entered into this study were those
endorsed by each of the participants on the Autism Spec-
trum Quotient [14]. The AQ comprises 50 questions, cov-
ering 5 domains each of 10 questions assessing areas of
relevance for the diagnosis of an autistic spectrum disor-
der, these being social skills, attention switching, atten-
tion to detail, communication and imagination. Each
question is rated as 'definitely agree', 'slightly agree',
'slightly disagree', and 'definitely disagree', with approxi-
mately half the items worded to produce a 'disagree'
response, and half an 'agree' response in a high scoring
person with AS. The test-retest and inter-rater reliabilities
of the AQ have also been shown to be good (ibid.). More-
over, the AQ has been found to be strongly predictive of a
clinical diagnosis of AS according to DSM-IV criteria [16];
and has been shown to work well cross-culturally [17]).
For the purpose of this study, for each item a score of 0,1,2
or 3 was assigned along the spectrum 'definitely agree',
'slightly agree', 'slightly disagree', and 'definitely disagree'
for items worded to produce a 'disagree' response in a
high scoring person with AS, and 3,2,1 and 0 for items
worded to produce an 'agree' response. Therefore, each
individual's scores ranged from 0 to 3 for each of the 50
AQ items, and 0 to 150 for the complete questionnaire,
with higher scores indicative of traits more typical of
ASCs. Subsequently, complete linkage cluster analysis was
employed [18], using SPSS Version 11 [19].
Results
AQ responses from a total of 388 individuals between the
ages of 16.6 and 78.0 years were initially considered. Of
these, 127 were female and 261 were male. There was no
difference in mean AQ score between those recruited from
the ARC volunteer database and those seen in the CLASS
clinic (ARC = 37.3, Clinic = 36.8: t = .67, P = 0.502). Mean
ages (ARC = 35.3 years, Clinic = 32.6 years) in the two
populations were similar. Considering gender distribu-
tion (ARC = male 57%, Clinic = male 79%, Fisher's exact
test P <0.001), the preponderance of males with respect to
females attending the diagnostic clinic was significantly
greater than was the case for members of the ARC volun-
teer data base. Although IQs were unfortunately not avail-
able, all participants had attended mainstream school. In
55 participants some AQ responses were missing and
these individuals were excluded, leaving questionnaires
from 333 individuals to be included in the cluster analy-
sis.
Whilst the 2, 3 and 4 cluster solutions produced groups
each with more than 10 participants, in contrast, solu-
tions with more than four clusters included one or more
groups with very small numbers (i.e. with less than 10).
The significance of groups with very small numbers such
as these is unclear, and therefore only the 2, 3 and 4 clus-
ter solutions were examined further. For each AQ item,
the group mean was calculated, allowing comparison
between groups for each of the 50 AQ items. By way of
illustration, Table 1 shows the group mean scores for the
4 cluster solution, shown graphically in Figure 1.
Discussion
Strikingly, each of these solutions was consistent with a
severity gradient. Considering the 4 cluster model for
example, although not all AQ items demonstrate a clear
severity gradient, 64% of the AQ items are consistent with
gradient of severity with Group 1 representing 'severe'
cases, Group 2 'moderately severe', Group 3 'moderate'
and Group 4 'mild'. Similar results were found for the 2
and 3 cluster models.
In summary, the results of this current analysis support a
unitary spectrum model, with clustering according to
severity. This study therefore seems primarily to agree
with that of Spiker and colleagues [12], who have argued
for a continuous severity gradient. In contrast, the results
did not provide support for Silverman et al. [7], who have
argued for subgroups.
There are several limitations to the current study that
should also be considered. The lack of IQ data precluded
us from examining the impact of cognitive functioning on
AQ scores. The spread of ages within the participant pop-
ulation, though excluding children below the age of 16,
was large. The smaller male excess in the ARC sample with
respect to the CLASS Clinic sample was unexpected. The
sex ratio in the clinic participants resembled that recorded
in many other studies of people with ASC. The clinic pop-
ulation were referred by other doctors (family doctors,
psychiatric services) who may have been influenced in
their willingness to refer to a specialist service by expecta-
tions that autism-like symptoms when seen in males may
be autism but when seen in females may have some non-
autistic cause. The observation that both the ARC-ascer-
tained and the clinic-ascertained samples had similar age
profiles and similar scores on the AQ suggests that people
with conditions of similar severity presented to both.
Although these various factors may have influenced the
results, it remains possible that a gradient of severity is an
independent observation and explains the variation
between people's clinical phenotype. Such a gradient may
not necessarily be the result of differences in autism symp-
toms per se, but might instead reflect the modifying effect
of another continuously distributed factor (or factors).
For example, IQ is continuously distributed in the popu-Page 3 of 6
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have mediated the gradient observed. Unfortunately, IQ
scores were not available for the participants of this study,
and so to examine this hypothesis further data are needed.
Similarly, personality traits vary quite considerably in the
general population and these may have a modifying effect
on the expression of the phenotype. This too needs further
investigation. However, the variation in severity observed
in this and previous studies may be due to a variation in
severity of autism itself, and, if so, this may be the result
Table 1: Mean Cluster scores for each AQ item in the 4 cluster solution
'mild' N = 32 'moderate' N = 40 'moderately severe' N = 140 'severe' N = 121
AQ1 1.75 1.95 2.46 2.37
AQ2 1.66 1.93 2.45 2.51
AQ3 0.88 0.73 0.63 2.02
AQ4 1.97 2.55 2.76 2.82
AQ5 2.06 1.9 2.39 2.45
AQ6 1.91 2.08 2.44 2.28
AQ7 1.13 1.6 2.12 2.32
AQ8 1.09 0.88 1.21 2.34
AQ9 1.41 1.48 1.59 1.68
AQ10 1.75 1.95 2.44 2.79
AQ11 2.16 2.48 2.81 2.82
AQ12 2.22 2.4 2.57 2.65
AQ13 1.47 1.55 2.36 2.4
AQ14 1.47 1.03 1.52 2.4
AQ15 1.81 1.98 2.41 2.4
AQ16 1.75 2.2 2.56 2.64
AQ17 1.56 2.2 2.58 2.77
AQ18 1.25 1.48 1.76 2.09
AQ19 1.31 1.25 1.96 1.83
AQ20 0.88 1.4 1.68 2.4
AQ21 1.19 1.28 1.42 1.93
AQ22 1.88 2.28 2.66 2.79
AQ23 1.84 1.8 2.46 2.33
AQ24 1.59 2.1 2.09 1.97
AQ25 1.59 1.83 2.51 2.56
AQ26 1.59 2.43 2.53 2.74
AQ27 1.78 1.85 2.29 2.68
AQ28 1.63 1.73 2.24 2.36
AQ29 1.84 2.07 1.62 1.79
AQ30 1.56 1.52 1.59 1.34
AQ31 1.16 1.8 2.02 2.27
AQ32 1.72 1.9 2.25 2.61
AQ33 0.91 1.25 1.81 2.09
AQ34 1.13 1.48 2.19 2.21
AQ35 0.84 2.15 1.68 2.28
AQ36 1.53 2.03 2.31 2.77
AQ37 1.72 1.55 2.09 2.52
AQ38 1.78 2.5 2.67 2.9
AQ39 1.5 2.18 2.31 2.42
AQ40 1.47 1.25 1.96 2.55
AQ41 1.06 2.1 2.29 2.13
AQ42 1.16 1.92 2.37 2.6
AQ43 1.41 2.32 2.36 2.43
AQ44 1.38 1.68 2.41 2.46
AQ45 1.34 2.18 2.37 2.73
AQ46 1.87 2.55 2.69 2.86
AQ47 1.19 1.38 2.18 2.34
AQ48 1.75 1.67 2.11 2.4
AQ49 1.81 1.73 1.42 1.47
AQ50 1.44 1.68 2.12 2.73Page 4 of 6
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model proposes that there are several susceptibility genes
for autism, and that the more of these genes a person has,
the more severe will be the phenotype. These genes may
be conceptualised as conferring a general susceptibility to
autism rather than comprising different genes that con-
tribute to different aspects of the phenotype such as social
interaction, communication, rigidity and so forth. The
results of the current study and previous ones [12,13] sup-
port this model. If a genetic dosage effect does, indeed,
explain phenotypic variation, then the first degree rela-
tives would show a similar trend of severity for autism
traits. Unfortunately, data is not available from family
members for this hypothesis to be tested in the current
study.
These analyses should be considered as exploratory. The
ideas developed in this paper need to be tested further for
replication, and examined across a wider spectrum of dis-
ability. Clearly what is now needed is the exploration of
factors that might contribute to the existence of a severity
gradient, and more specifically whether this can best be
explained by the modifying effect of another continuously
distributed factor, such as IQ, or whether it is indicative of
ASCs being inherited as a single, continuous severity
dimension. Ultimately, examination of inter versus intra-
familial clustering, both in affected sib-pairs, and within
their unaffected parents, will be able to investigate the
hypothesis that the severity gradient is the result of the
modifying effect of another non-ASC factor, such as IQ.
Until this is clearer, difficulties in identifying ASC suscep-
tibility genes may continue.
Conclusion
The clinical heterogeneity observed in people with ASCs,
together with the strong hereditability recognised in these
conditions, has led to a debate as to whether this variation
in manifestation is associated with either distinct genetic
sub-types with quite different clinical symptoms or with a
common basis but with clinical variability originating as
a result of an overall variation in severity between individ-
uals. Examination of the responses of over 300 individu-
als with Asperger's syndrome or high functioning autism
to the 50 items of a questionnaire rating the occurrence of
a wide range of behaviors characteristic of ASC provides
evidence that the observed clinical spectrum is associated
with a gradient in the overall severity of the ASC rather
than with the presence of different specific symptom pro-
Group mean scores for each of the fifty AQ itemsFigure 1
Group mean scores for each of the fifty AQ items.
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variation in severity however remain to be established.
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